UPDATE: Goldman Sachs Starts Pfizer (PFE) at Neutral
Tweet Send to a Friend
(Updated - December 17, 2021 6:43 AM EST)
Goldman Sachs analyst Chris Shibutani initiates coverage on Pfizer (NYSE: PFE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani initiates coverage on Pfizer (NYSE: PFE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


